News update from Datamonitor
May 1, 2007Research and Development, Sales and Marketing
Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …
Industry lobbies ministers ahead of OFT decision
May 1, 2007Sales and Marketing
The UK pharmaceutical industry is using a series of meetings with government ministers to push for a rejection of the …
Can pharma meet the generic challenge?
May 1, 2007Sales and Marketing generics, pharma, sales
The global pharmaceutical industry has generally been seen as one of the most successful industries in delivering revenue growth with …
Pharma news from Datamonitor
April 26, 2007Research and Development, Sales and Marketing
Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …
Product update from Datamonitor
April 26, 2007Research and Development, Sales and Marketing
Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …
Making Europe’s salesforces leaner and meaner
April 26, 2007Sales and Marketing Europe, representatives, sales, strategy
The world of pharma salesforce management is witnessing a serious move away from mass detailing to a system based on …
UK science at a ‘tipping point’
April 26, 2007Research and Development
The future for the UK's medical science base looks very bright, according to leading figures in the government, science and …
Januvia launched in UK
April 25, 2007Sales and Marketing Januvia, diabetes
Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …
Free healthcare a ‘mirage’ in UK
April 25, 2007Sales and Marketing Doctors for reform
UK patients routinely top up their care by going private, undermining politicians’ claims the NHS is free-to-all, according to a …
AZ’s latest purchase fails to impress investors
April 25, 2007Sales and Marketing
AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the £15.6 billion …
Clinical trial news from Datamonitor
April 18, 2007Research and Development
Array BioPharma receives payment for cancer inhibitorArray BioPharma has received a $2 million milestone payment from AstraZeneca after its MEK …
Product news roundup from Datamonitor
April 18, 2007Sales and Marketing
Changing of the guard in HIV treatmentThe HIV market is forecast to grow from $7.1 billion in 2005 to an …
Lilly upbeat after strong start to year
April 18, 2007Sales and Marketing
Stronger than expected sales and profits in early 2007 has lifted Lilly, prompting the US pharma company to raise its …
Public to get clearer picture of hospital bugs
April 18, 2007NHS
The government is to turn up the heat on trusts over rising levels of hospital infections by showing the public …
Diabetes drug costs double in five years
April 18, 2007Sales and Marketing
A growing number of patients and a switch to newer medicines has brought about a doubling of England's spending on …
Athena wins two Pfizer accounts
April 18, 2007Medical Communications
Athena Medical PR has been appointed by Pfizer UK to run its PR campaigns for two of its anti-infective products: …
Europe’s buoyant biotech set for further growth
April 16, 2007Research and Development, Sales and Marketing biotech
A new comprehensive survey of the world's biotechnology industry shows the sector to be in great health, with indications of …
NICE in the dock: what the judicial review means for pharma
April 16, 2007Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review
The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …
Product news from Datamonitor
April 16, 2007Research and Development, Sales and Marketing
Carrington Laboratories to manufacture sublingual vaccinesCarrington Laboratories has reported that its subsidiary DelSite Biotechnologies has entered into an agreement with …
Company news from Datamonitor
April 16, 2007Sales and Marketing
Avenir plans restructure and ends AZ collaborationsAvanir Pharmaceuticals has said it plans to implement a restructuring plan and has ended …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
